Limited Availability: $799 preorder (reg. $1,299). Save $500. Reserve for $49 →
Home
The Science
Cancer
How It Works
Pricing
About
Contact
EN FR DE 简体 繁體
Reserve Your Test for $49
Person receiving a routine blood draw in a clean, modern clinic setting

How miCheckup Works

Four steps. One blood draw. Results in approximately 4–8 weeks. miCheckup is a microRNA multi-cancer early detection (MCED) test — and getting tested is as simple as routine blood work.

Reserve Your Test for $49

Preorder $799 · Regular $1,299 · Save $500

Home › How It Works
The Process Your Results MRI Included FAQ Reserve for $49
The Process

How miCheckup works, step by step.

No referral. No fasting. No scans unless needed. Four clear steps from order to results.

Person ordering a health test on their laptop at a kitchen table
Clean, modern blood collection clinic interior with patient and technician
Laboratory technician analyzing blood samples with advanced scientific equipment
Patient and physician having a relaxed, reassuring video consultation
01
/04

Order Your Test Online

Visit micheckup.com and reserve your miCheckup MCED test with a $49 deposit. Early-access customers receive the $799 preorder price before the regular $1,299 price returns.

Reserve for $49
02
/04

Get a Simple Blood Draw

Book a convenient time at a partner collection centre near you. One standard blood draw — the same process as routine lab work. About 10 minutes. No fasting required. Multiple locations across Ontario.

View Locations
03
/04

Your Sample Is Analyzed

Your blood sample is processed entirely within Canada at an accredited Canadian laboratory. Our microRNA analysis examines thousands of molecular data points for patterns associated with multiple solid tumor cancers — using the validated algorithms behind our MCED platform.

04
/04

Receive Your Results

In approximately 4–8 weeks, a physician reviews your results with you. Clear explanation. No confusing report to decode alone. If a suspected cancer signal is identified, a whole-body MRI and follow-up are included at no additional cost.

Person ordering a health test on their laptop at a kitchen table
01/04

Order Your Test Online

Visit micheckup.com and reserve your miCheckup MCED test with a $49 deposit. Early-access customers receive the $799 preorder price before the regular $1,299 price returns.

Reserve for $49
Clean, modern blood collection clinic interior with patient and technician
02/04

Get a Simple Blood Draw

Book a convenient time at a partner collection centre near you. One standard blood draw — the same process as routine lab work. About 10 minutes. No fasting required. Multiple locations across Ontario.

View Locations
Laboratory technician analyzing blood samples with advanced scientific equipment
03/04

Your Sample Is Analyzed

Your blood sample is processed entirely within Canada at an accredited Canadian laboratory. Our microRNA analysis examines thousands of molecular data points for patterns associated with multiple solid tumor cancers — using the validated algorithms behind our MCED platform.

Patient and physician having a relaxed, reassuring video consultation
04/04

Receive Your Results

In approximately 4–8 weeks, a physician reviews your results with you. Clear explanation. No confusing report to decode alone. If a suspected cancer signal is identified, a whole-body MRI and follow-up are included at no additional cost.

Your Results

Two possible outcomes — both with a clear path forward.

Every result comes with physician guidance and a next step.

When your microRNA analysis is complete, your result will fall into one of two categories:

Most Common Result

"No suspected cancer signal identified."

Our analysis did not detect disease-associated microRNA patterns in your blood at this time. This is reassuring, but it doesn't guarantee the absence of disease. We recommend annual testing to track changes in your molecular baseline over time.

Action Required

"Suspected cancer signal identified."

We detected molecular patterns that warrant further investigation. This is not a diagnosis — it's an early warning that puts you ahead of the timeline. Your next step is already in place: a whole-body MRI, included at no additional cost.

miCheckup is an MCED test — a multi-cancer early detection tool. It is not a diagnostic test. A suspected cancer signal identified result means your microRNA profile warrants investigation. Cancer diagnosis in Canada always requires confirmation through tissue biopsy by a pathologist.

View the Science
Person reviewing health information on a tablet in a bright living room
MRI Included

If a signal is found, the next scan is already covered.

A whole-body MRI is included if a suspected cancer signal is found — no separate referral, no additional cost, no delay.

Most people's results show no suspected cancer signals. But if yours do, you're not left figuring out what to do next.

A complete whole-body MRI is included in your miCheckup test at no additional cost. A physician orders the imaging, reviews the results with you, and guides you through every step — from interpretation to referral within the Canadian healthcare system.

A private whole-body MRI in Canada typically costs upwards of $4,000. With miCheckup, it's included if a suspected cancer signal is identified.

This is what sets the miCheckup MCED test apart: it's not just a result — it's a complete pathway from early signal to clinical follow-up.

View Pricing
Whole-body MRI suite with modern medical imaging equipment

An early warning for cancer. Made in Canada.

Multiple
Solid tumor cancers tested in a single blood draw — lung, colorectal, prostate, pancreatic, ovarian, liver, and more
99%+
Specificity — fewer than 1 in 100 people without cancer receive a false signal
$799
Limited preorder price — reserve today with a $49 deposit before the regular $1,299 price returns
Your Data, Your Future

Your microRNA data unlocks more than a single test.

Your miCheckup test captures a molecular snapshot of your body at this moment in time. As a microRNA multi-disease screening (MMDS) platform, the same data may one day reveal insights beyond cancer. One investment today opens the door to ongoing discovery.

Explore the Science
Abstract warm-toned scientific visualization of molecular structure

Cancer Early Warning — Available Now

Read Less
miCheckup's MCED test analyzes your microRNA patterns for signals associated with early-stage cancer across multiple solid tumor types — most of which have no public screening program in Canada.

FAQs

Everything you need to know about the miCheckup process.

Contact Us
Serene Canadian landscape with a lake and mountains in soft light

Do I need a doctor's referral?

+
No. miCheckup is a direct-to-consumer laboratory service. You can order online without any referral or prescription. A physician reviews your results as part of the service.

Where do I get my blood drawn?

+
At a partner collection centre — multiple locations across Ontario. The blood draw is routine — about 10 minutes, no fasting required.

Is this a diagnostic test?

+
No. miCheckup is a multi-cancer early detection (MCED) test — a laboratory-developed test (LDT) that measures circulating microRNA levels. It identifies signals that warrant further investigation. Cancer diagnosis in Canada always requires a tissue biopsy confirmed by a pathologist.

How accurate is the test?

+
Published studies show greater than 99% specificity and greater than 90% sensitivity for the majority of validated cancer types, using thousands of peer-reviewed blood samples. No test is perfect — that's why we recommend annual testing alongside continued regular healthcare.

What cancers does miCheckup test for?

+
miCheckup tests for multiple solid tumor cancers: lung, colorectal, prostate, pancreatic, ovarian, liver, kidney, bladder, stomach, uterine, head and neck, and esophageal. Nine of these have no public screening program in Canada.

What happens if a suspected cancer signal is found?

+
A whole-body MRI is included at no additional cost. A physician reviews the imaging results with you and guides you through next steps, including referral within the Canadian healthcare system if needed.

How is this different from genetic testing?

+
Genetic tests look at your DNA — your inherited blueprint that never changes. microRNA testing measures what's happening in your body right now. Your DNA shows inherited risk. Your microRNA shows current biological activity, including early signals that disease may be developing.

How much does it cost?

+
Early-access preorder price is $799, with a $49 deposit to reserve your test. Regular price is $1,299 CAD. This includes your microRNA test, analysis, physician review, and — if a suspected cancer signal is detected — whole-body MRI at no extra cost.
Person smiling warmly in soft natural light with a hopeful, empowered tone

Four simple steps.One blood draw. A real early warning about your cancer risk.That's what miCheckup is for.

Reserve Your Test for $49

Preorder $799 · Regular $1,299 · Save $500

Important Safety Information

+

miCheckup is intended for adults at or above the age of majority in their province (18 or older in most provinces; 19 or older in British Columbia, New Brunswick, Newfoundland and Labrador, Nova Scotia, Northwest Territories, Nunavut, and Yukon). miCheckup is a multi-cancer early detection (MCED) test — an early warning test intended to identify a suspected cancer signal associated with multiple solid tumor cancers from a single blood draw. miCheckup does not detect all cancers and should be used in addition to routine cancer screening tests recommended by your healthcare provider.

Use of miCheckup is not recommended in individuals who are pregnant or planning pregnancy, under the age of majority in their province, currently undergoing active cancer treatment, or currently experiencing symptoms that may indicate cancer. If you are experiencing symptoms, please consult your physician directly.

Results should be interpreted by a healthcare provider in the context of your medical history, clinical signs, and symptoms. All miCheckup results are reviewed with you by a physician. A result of "no suspected cancer signal identified" does not rule out cancer. A result of "suspected cancer signal identified" is not a diagnosis — it requires confirmatory diagnostic evaluation by medically established procedures, which is why a whole-body MRI and physician follow-up are included in your miCheckup test.

If a suspected cancer signal is identified but cancer is not confirmed with further testing, it could mean that cancer is not present, or that testing was insufficient to detect cancer — including due to the cancer being located in an area or of a type not well represented in the miCheckup signal. False positive results (a suspected cancer signal identified when cancer is not present) and false negative results (no suspected cancer signal identified when cancer is present) do occur.

miCheckup is a complement to, not a replacement for, standard cancer screening programs. Continue all recommended screening — including mammography, Pap/HPV testing, and colorectal screening (FIT or colonoscopy) — as directed by your healthcare provider. Cancer diagnosis in Canada always requires a tissue biopsy confirmed by a pathologist. If a suspected cancer signal is identified, imaging and clinical workup by your healthcare team will determine the actual status. Many findings turn out to be benign after further investigation.

Laboratory/Test Information

+

miCheckup is a multi-cancer early detection (MCED) Laboratory-Developed Test (LDT), performed at an accredited Canadian medical laboratory certified by the Institute for Quality Management in Healthcare (IQMH). In Canada, LDTs are regulated as a clinical laboratory service under provincial and territorial laboratory oversight. Your blood sample is collected, processed, and analyzed entirely within Canada.

The miCheckup microRNA analysis is based on peer-reviewed research published in Scientific Reports (Nature Portfolio, 2024) and Cancers (MDPI, 2022), validated on thousands of peer-reviewed blood samples, with ongoing validation through the Ontario Health Study using 4,000+ Canadian blood samples.

Published validation shows greater than 99% specificity and greater than 90% sensitivity for the majority of cancer types in the current miCheckup panel of multiple solid tumor cancers. Performance may vary by cancer type and individual factors. For a detailed breakdown of sensitivity and specificity by cancer type, and the complete list of cancers currently in the miCheckup panel, visit The Science.

All personal health data is stored in Canada and handled in accordance with the Personal Information Protection and Electronic Documents Act (PIPEDA) and applicable provincial health privacy legislation, including the Personal Health Information Protection Act (PHIPA) in Ontario.

miCheckup is currently available in Ontario, expanding across Canada. For the full safety, regulatory, and performance disclosure, see Important Information.

References

+
  1. Zhang J, Rui H, Hu H. "Noninvasive multi-cancer detection using blood-based cell-free microRNAs." Scientific Reports 14, 22136 (2024). doi.org
  2. Zhang A, Hu H. "A Novel Blood-Based microRNA Diagnostic Model with High Accuracy for Multi-Cancer Early Detection." Cancers 14(6), 1450 (2022). doi.org
  3. The Nobel Foundation. "The Nobel Prize in Physiology or Medicine 2024 — Victor Ambros and Gary Ruvkun." nobelprize.org